Biogen Idec (NQ: BIIB )

200.04 +6.86 (+3.55%)

Streaming Delayed Price Updated: 2:27 PM EDT, Apr 24, 2024 Add to My Watchlist

Price and Volume

Volume	2,066,631
Open	198.97
Bid (Size)	199.94 (2)
Ask (Size)	200.13 (4)
Prev. Close	193.18
Today's Range	198.97 - 205.75
52wk Range	189.44 - 319.76
Shares Outstanding	144,000,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why

Today 14:23 EDT

Discover the challenges facing Leqembi, the first Alzheimer's drug shown to slow progression. Skepticism among doctors and concerns about efficacy and costs hinder widespread adoption despite FDA...

Via Benzinga

Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?

Today 13:40 EDT

Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the...

Via Benzinga

Performance

YTD	-25.28%	-25.28%
1 Month	-7.68%	-7.68%
3 Month	-20.52%	-20.52%
6 Month	-20.65%	-20.65%
1 Year	-31.73%	-31.73%

More News

Biogen (BIIB) Q1 2024 Earnings Call Transcript

Today 12:45 EDT

Via The Motley Fool

Where Biogen Stands With Analysts

April 11, 2024

Via Benzinga

Looking Into Biogen's Recent Short Interest

April 03, 2024

Via Benzinga

Forecasting The Future: 18 Analyst Projections For Biogen

March 25, 2024

Via Benzinga

Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings

Today 12:12 EDT

Via Benzinga

BIIB Stock Earnings: Biogen Beats EPS, Misses Revenue for Q1 2024

Today 11:53 EDT

Via InvestorPlace

Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline?

Today 6:45 EDT

Via Investor's Business Daily

Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally

Today 6:37 EDT

Via Benzinga

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week

April 21, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session

April 09, 2024

Via Benzinga

10 Big-Name Stocks Near 52 Week Lows: Are They A Buy?

March 29, 2024

Via Talk Markets

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback

March 28, 2024

Via Investor's Business Daily

Tuesday Talk: Big-Tech Under Attack

March 26, 2024

Via Talk Markets

Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich

March 25, 2024

Via InvestorPlace

European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab

March 22, 2024

Via Benzinga

Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

March 21, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session

March 20, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session

March 19, 2024

Via Benzinga

10 Big-Name Stocks Near 52-Week Lows: Are They A Buy?

March 16, 2024

Via Talk Markets

Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

March 14, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Fed Rate Cut Expectations Rise After February Jobs Report: Friday's Stock Movers

March 08, 2024

Via Benzinga

Are These 5 Undervalued Stocks Ready to Break Out?

March 08, 2024

Via MarketBeat

Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision

March 08, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.